Experts to Discuss AI and Advanced Cancer Care at Riyadh Conference
The fourth Middle East Society of Therapeutic Radiation Oncology conference will focus on artificial intelligence, modern cancer treatment technologies.
The fourth Middle East Society of Therapeutic Radiation Oncology conference is set to take place at Alfaisal University in Riyadh from November 21-22.
Experts, researchers, and representatives from international pharmaceutical and medical technology companies will gather for the event, which focuses on artificial intelligence and modern cancer treatment technologies.
Scientific sessions will begin with discussions on recent developments in radiation therapy and oncology technologies across major Gulf centers.
Speakers from Saudi Arabia, Qatar, Bahrain, Oman, Kuwait, and the UAE are scheduled to participate, offering insights into advancements within their respective countries.
The conference also includes panel discussions covering modern cancer treatment technologies in Egypt, Jordan, Morocco, Turkey, and Iraq.
These sessions aim to provide a comprehensive overview of how different nations are approaching cutting-edge oncology treatments.
A specialized Saudi team will present efforts to advance proton therapy – an advanced technology known for reducing radiation-related side effects, particularly in children – as well as the challenges faced in implementing it within the Kingdom.
Additionally, Professor Fady Geara, chairman of the Department of Radiation Oncology at Cleveland Clinic, is scheduled to give a presentation on carbon ion therapy.
This precise particle therapy targets cancer cells effectively, especially those resistant to conventional treatments.
Representatives from the King Hussein Cancer Center in Jordan will share their experience with MR-guided radiotherapy, highlighting its precision and technological advancements.
The conference program also includes sessions on multidisciplinary cancer care, basic and applied research, clinical trials, an interactive platform for speakers and patients, and a technical exhibition featuring pharmaceutical and medical technology companies.
Dr. Saad Al-Rashidi, the conference president, emphasizes that hosting the event at Alfaisal University underscores Saudi Arabia's dedication to investing in health knowledge and medical technology.
The conference has reportedly been expanding each year in terms of both participation and scientific presentations, solidifying its position as a leading platform for exchanging expertise in radiation technology in the Middle East.
Experts, researchers, and representatives from international pharmaceutical and medical technology companies will gather for the event, which focuses on artificial intelligence and modern cancer treatment technologies.
Scientific sessions will begin with discussions on recent developments in radiation therapy and oncology technologies across major Gulf centers.
Speakers from Saudi Arabia, Qatar, Bahrain, Oman, Kuwait, and the UAE are scheduled to participate, offering insights into advancements within their respective countries.
The conference also includes panel discussions covering modern cancer treatment technologies in Egypt, Jordan, Morocco, Turkey, and Iraq.
These sessions aim to provide a comprehensive overview of how different nations are approaching cutting-edge oncology treatments.
A specialized Saudi team will present efforts to advance proton therapy – an advanced technology known for reducing radiation-related side effects, particularly in children – as well as the challenges faced in implementing it within the Kingdom.
Additionally, Professor Fady Geara, chairman of the Department of Radiation Oncology at Cleveland Clinic, is scheduled to give a presentation on carbon ion therapy.
This precise particle therapy targets cancer cells effectively, especially those resistant to conventional treatments.
Representatives from the King Hussein Cancer Center in Jordan will share their experience with MR-guided radiotherapy, highlighting its precision and technological advancements.
The conference program also includes sessions on multidisciplinary cancer care, basic and applied research, clinical trials, an interactive platform for speakers and patients, and a technical exhibition featuring pharmaceutical and medical technology companies.
Dr. Saad Al-Rashidi, the conference president, emphasizes that hosting the event at Alfaisal University underscores Saudi Arabia's dedication to investing in health knowledge and medical technology.
The conference has reportedly been expanding each year in terms of both participation and scientific presentations, solidifying its position as a leading platform for exchanging expertise in radiation technology in the Middle East.
